Chimeric compounds targeting proteins, compositions, methods, and uses thereof

申请号 US15599401 申请日 2017-05-18 公开(公告)号 US09938302B2 公开(公告)日 2018-04-10
申请人 Bio TheryX, Inc.; 发明人 Kyle W. H. Chan; Leah Fung; Robert Sullivan; Paul E. Erdman; Frank Mercurio; Eduardo Torres;
摘要 The present invention provides chimeric compounds that modulate protein function, to restore protein homeostasis, including cytokine, aiolos, and/or ikaros activity, TNF-alpha activity, CK1-alpha activity and cell-cell adhesion. The invention provides methods of modulating protein-mediated diseases, such as cytokine-mediated diseases, disorders, conditions, or responses. Compositions, including in combination with other cytokine and inflammatory mediators, are provided. Methods of treatment, amelioration, or prevention of protein-mediated diseases, disorders, and conditions, such as cytokine-mediated diseases, disorders, and conditions, including inflammation, fibromyalgia, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, inflammatory bowel diseases, Crohn's disease, ulcerative colitis, uveitis, inflammatory lung diseases, chronic obstructive pulmonary disease, Alzheimer's disease, organ transplant rejection, and cancer, are provided.
权利要求
说明书全文
QQ群二维码
意见反馈